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Background: Outbreaks of avian influenza (AI) caused by infection with low pathogenic H9N2 viruses have
occurred in poultry, resulting in serious economic losses in Asia and the Middle East. It has been difficult to
eradicate the H9N2 virus because of its low pathogenicity, frequently causing in apparent infection. It is important
for the control of AI to assess whether the H9N2 virus acquires pathogenicity as H5 and H7 viruses. In the present
study, we investigated whether a non-pathogenic H9N2 virus, A/chicken/Yokohama/aq-55/2001 (Y55) (H9N2),
acquires pathogenicity in chickens when a pair of di-basic amino acid residues is introduced at the cleavage site of
its HA molecule.
Results: rgY55sub (H9N2), which had four basic amino acid residues at the HA cleavage site, replicated in MDCK
cells in the absence of trypsin after six consecutive passages in the air sacs of chicks, and acquired intravenous
pathogenicity to chicken after four additional passages. More than 75% of chickens inoculated intravenously with
the passaged virus, rgY55sub-P10 (H9N2), died, indicating that it is pathogenic comparable to that of highly
pathogenic avian influenza viruses (HPAIVs) defined by World Organization for Animal Health (OIE). The chickens
inoculated with the virus via the intranasal route, however, survived without showing any clinical signs. On the
other hand, an avirulent H5N1 strain, A/duck/Hokkaido/Vac-1/2004 (Vac1) (H5N1), acquired intranasal pathogenicity
after a pair of di-basic amino acid residues was introduced into the cleavage site of the HA, followed by two
passages by air sac inoculation in chicks.
Conclusion: The present results demonstrate that an H9N2 virus has the potential to acquire intravenous
pathogenicity in chickens although the morbidity via the nasal route of infection is lower than that of H5N1 HPAIV.
Background
Each of the known subtypes of the influenza A virus
(H1 to H16 and N1 to N9) is circulating in water birds,
especially in migratory ducks [1]. A highly pathogenic
avian influenza virus (HPAIV) is generated when a non-
pathogenic virus brought in by migratory birds from
nesting lakes in the north is transmitted to chickens via
domestic ducks, geese, quails, turkeys, etc. and acquires
pathogenicity for chickens with repeated multiple infec-
tions in the chicken population [2-6]. The hemaggluti-
nins (HAs) of HPAIVs differ from those of low
pathogenic avian influenza viruses (LPAIVs) with a pair
of di-basic amino acid residues at their cleavage site [7].
This structure permits ubiquitous proteases such as
furin and PC6, which recognize multiple basic amino
acids, to cleave the HA, leading to systemic infection in
chickens. By contrast, HAs of LPAIVs are cleaved only
by trypsin-like proteases which are expressed in the cells
lining the respiratory or intestinal tracts, so that the
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any medium, provided the original work is properly cited.viruses cause only localized infections, resulting in mild
or asymptomatic diseases. It is presently believed that
the strains only with H5 or H7 HAs become HPAIVs
during extensive infections in chicken populations [8].
The reason why the subtypes of HPAIVs are restricted
to H5 and H7 is not known although a model demon-
strating that H5 HA is cleaved by furin through molecu-
lar docking analyses have been proposed [9,10].
H9N2 avian influenza virus strains have caused out-
breaks in poultry, resulting in serious economic losses
in Asia and the Middle East [11-19]. The causal strains,
however, are avirulent and none of them have multiple
basic amino acid residues at the cleavage site of the HA
[12,15]. No specific-pathogen-free chickens experimen-
tally infected with H9N2 isolates from diseased chickens
showed any clinical symptoms [20]. Co-infection of
H9N2 viruses with bacteria such as Staphylococcus aur-
eus and Haemophilus paragallinarum or with attenuated
coronavirus vaccine exacerbated the disease [19,21-23].
Since H9N2 viruses have been isolated not only from
domestic birds but also from pigs and humans, the H9
virus has the potential to cause a next pandemic in
humans [17,24-27]. It is important for controlling avian
influenza and for preparing for pandemic influenza to
assess whether the H9N2 virus aquires pathogenicity as
H5 and H7 viruses. In the present study, we introduced
a pair of di-basic amino acid residues into the cleavage
site of the H9 and H5 HAs of non-pathogenic strains.
These mutant H9 and H5 viruses were then serially pas-
saged in the air sacs of chicks and their pathogenicity
was assessed by inoculation to four-week-old chickens
via intravenous and intranasal routes.
Results
Generation and characterization of mutant viruses
To investigate whether a non-pathogenic H9 influenza
virus, A/chicken/Yokohama/aq-55/2001 (Y55) (H9N2)
acquires pathogenicity on the introduction of a pair of
di-basic amino acid residues at their HA cleavage site,
rgY55sub (H9N2) was generated by site-directed-
mutagenesis and reverse genetics. Amino acid sequences
at the HA cleavage site of the mutant strain are shown in
Figure 1A. The RKKR motif was introduced into the H9
HA cleavage site to give a pair of di-basic amino acid
residues that is known to be a sine qua non for H5 and
H7 viruses to become highly pathogenic to chickens. The
virus with the insertion of basic amino acid residues at
the H9 HA cleavage site was not rescued from plasmid-
transfected cells (data not shown). As a positive control,
rgVac1ins (H5N1) was generated by inserting the RRKKR
motif, rather than RKKR, into the HA of the non-patho-
genic virus A/duck/Hokkaido/Vac-1/2004 (Vac1) (H5N1)
since recent H5 HPAIV isolates have the motif as inser-
tion mutation. rgVac1sub (H5N1) was also generated to
examine whether subtitution mutation with basic amino
acid residues at the HA cleavage site contributed to
acquisition of pathogenicity for chickens.
rgY55sub (H9N2) and rgVac1ins (H5N1) required
trypsin to replicate in MDCK cells, and showed similar
levels of growth to their parental viruses (Table 1).
Chickens intravenously inoculated with rgY55sub
(H9N2) or rgVac1ins (H5N1) did not show any signs of
disease. rgVac1sub (H5N1) replicated in MDCK cells
w i t h o u te x o g e n o u st r y p s i n ,a n do n eo ft h ee i g h tc h i c k -
ens inoculated with the virus showed slight depression
at one day post-infection.
Consecutive passages of the viruses in the air sacs of
chicks
The H9 mutant virus was serially passaged in the air
sacs of chicks to assess whether it acquires pathogenicity
as did H5 viruses. The passaged viruses were tested for
their growth potential in MDCK cells and pathogenicity
for chickens (Table 1). rgY55sub (H9N2) replicated in
MDCK cells in the absence of trypsin and killed all of
the chicks after six consecutive passages. Two of the
eight four-week-old chickens inoculated intravenously
with rgY55sub-P8 (H9N2) died within five days. Conse-
quently, over 75% of the chickens intravenously infected
with rgY55sub-P10 (H9N2) died by two days post
inoculation, and its pathogenicity was comparable to
that of the known HPAIVs [28].
H5N1 mutant viruses acquired intravenous pathogeni-
city by passaging twice in chicks; all of the chickens
rgY55 (H9N2) CCT GCT AGA TCA AGT AGA / GGA
P A R SSR G
rgY55sub (H9N2) CCT GCT AGA AAA AAG AGA / GGA
P A RKKR G
rgVac1 (H5N1) CCT CAA AGA GAA ACA                           AGA / GGA
P Q R ET R G
HA1 HA2
rgVac1sub (H5N1) CCT CGA AGA AAA AAA                           AGA / GGA
P R RKK R G
rgVac1sub-P1 (H5N1) CCT CGA AGA AGA AAA AAA AGA / GGA
P R RK K R G R
rgVac1ins (H5N1) CCT CAA AGA GAA AGA AGA AAA AAG AGA / GGA







Figure 1 Nucleotide and amino acid sequences at the HA
cleavage site of each virus. (A) Mutations were introduced into
the HA genes of rgY55 (H9N2) and rgVac1 (H5N1) strains to give
multibasic amino acids at their cleavage sites by site-directed
mutagenesis. Mutation sites were underlined and deduced amino
acid sequences were depicted in italics. Basic amino acids were
shown in bold. (B) Nucleotide and amino acid sequences at the HA
cleavage site of rgVac1sub-P1 (H5N1). rgVac1sub (H5N1) acquired an
additional argenine residue represented by the codon AGA after
one passage in chickens.
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(H5N1) or rgVac1ins-P2 (H5N1).
Amino acid changes of the viruses during consecutive
passages in the air sacs of chicks
Nucleotide sequences of the eight segmented genomes
of the viruses passaged in the air sacs of chicks were
analyzed and compared with those of each parental
virus. Leu234 (equivalent to position 226 of H3 HA) in
the HA of rgY55sub (H9N2) was substituted with gluta-
mine at the initial passage (Table 2). No other amino
acid change was observed up to the fifth passage. Four
amino acids in the HA, NA and M2 changed at the
sixth passage. One of the asparagine-linked glycosylation
sites on the HA was lost by Asn29His mutation. In
total, eight amino acid differences were found between
rgY55sub (H9N2) and rgY55sub-P10 (H9N2). Five and
one amino acid changes were found in the PA, HA, M1
and M2 of rgVac1sub-P2 (H5N1), and the HA of rgVa-
c1ins-P2 (H5N1), respectively (Table 3). It is worth not-
ing that one argenine was inserted at the HA cleavage
site of rgVac1sub (H5N1) after one passage in chickens
(Figure 1B).
Pathogenicity of the viruses on intranasal infection in
chickens
To examine whether the pathogenicity of each virus via
the intranasal route of infection correlates with that via
intravenous route, three 4-week-old chickens were intra-
nasally inoculated with the viruses of 10
6.5 50% egg
infectious dose (EID50) and observed for clinical signs
until day 14 post-infection (Table 4). All chickens inocu-
lated with rgY55sub-P10 (H9N2) or its parental rgY55-
sub (H9N2) survived without showing any clinical signs,
and serum antibodies were detected (1:128-2,048 HI
titers), indicating that virus replication occurred.
One of the three chickens inoculated with rgVac1sub
(H5N1) or rgVac1ins (H5N1) showed seroconversion
after 14 days while no chickens were susceptible to infec-
tion with rgVac1 (H5N1). Both of rgVac1sub-P2 (H5N1)
and rgVac1ins-P2 (H5N1) were pathogenic, killing two of
the three chickens by day 11 post-inoculation.
Additional passages of the Vac1-based viruses in chickens
One of the three chickens intranasally inoculated with
rgVac1sub-P2 (H5N1) or rgVac1ins-P2 (H5N1) did not
Table 1 Growth potential in MDCK cells and pathogenicity for chicken of each virus
Viruses Plaque formation (log PFU/ml) Pathogenicity (number of dead/sick/total )
With trypsin Without trypsin 3-day-old chicks (air sac inoculation) 4-week-old chickens (intravenous inoculation)
rgY55 (H9N2) 8.1 -
a NT
b 0/0/8
rgY55sub (H9N2) 8.0 - 0/0/3 0/0/8
rgY55sub-P5 (H9N2) 7.6 - 0/0/4 0/0/8
rgY55sub-P6 (H9N2) 7.2 6.7 3/3/3 0/1/8
rgY55sub-P7 (H9N2) 7.8 7.5 3/3/3 0/5/8
rgY55sub-P8 (H9N2) 7.6 7.6 3/3/3 2/7/8 (4.0)
c
rgY55sub-P9 (H9N2) 7.2 6.9 3/3/3 1/8/8 (10.0)
rgY55sub-P10 (H9N2) 6.5 6.1 3/3/3 6/8/8 (1.8)
rgVac1 (H5N1) 7.6 - NT 0/0/8
rgVac1sub (H5N1) 7.6 7.8 0/0/3 0/1/8
rgVac1sub-P1 (H5N1) 6.8 6.8 3/3/3 3/5/8 (5.3)
rgVac1sub-P2 (H5N1) 6.4 6.5 6/6/6 8/8/8 (2.6)
rgVac1ins (H5N1) 7.3 - 0/0/3 0/0/8
rgVac1ins-P1 (H5N1) 7.8 7.1 3/3/3 6/7/8 (6.8)
rgVac1ins-P2 (H5N1) 7.1 7.1 4/4/4 6/8/8 (4.4)
a A plaque was not observed.
b Not tested.
c Mean death days are shown in parentheses.
Table 2 Amino acid changes during consecutive passages
of rgY55sub (H9N2)
Passage number PB2 HA NP NA M2
271
a 29 234 357 391 54 195 51
P0 T N L A N W T I
P1-P5 .
b .Q . . . . .
P6 . H Q D . . A T
P7 . H Q D N/D
c .AT
P8 T/A H Q D N/D . A T
P9 T/A H Q D N/D G A T
P10 A H Q D D G A T
a Methionine encoded by the AUG start codon is defined as position 1.
b Periods indicate same amino acids as the parental virus.
c Amino acid quasispecies are observed.
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viruses did not extensively replicate in chickens. rgVac1-
sub-P3 (H5N1) and rgVac1ins-P3 (H5N1) were prepared
from the brain homogenates of the chickens that died
on day 11 post-intranasal inoculation with the P2
viruses. Additional amino acid changes were found in
P 3v i r u s e s( T a b l e3 ) .T oi n v e s t i g a t ew h e t h e rt h eP 3
viruses show higher pathogenicity in chicken, the viruses
were inoculated via intranasal route. Mortality rate of
chickens inoculated with the P3 viruses was equal to
that with P2 viruses (Table 4).
Growth potential of the H9N2 and H5N1 viruses in
chickens
To investigate whether tissue tropism of the viruses was
involved in their pathogenicity, we determined viral
titers in the tissue and blood samples from four-week-
old chickens intranasally inoculated with each virus on
three days post infection (Table 5). rgY55 (H9N2) and
rgVac1 (H5N1) were scarcely recovered from the sam-
ples, and the mutant strains before passage in chicks
showed broader tissue tropism than the parental viruses.
None of the chickens inoculated with rgY55sub-P10
(H9N2) showed any signs of disease, and viruses were
recovered from each of the samples except the brain
and the blood. One of the three chickens inoculated
with rgVac1sub-P2 (H5N1) showed clinical signs such
as depression, and the viruses were recovered from vir-
tually all of the organs and blood samples. The remain-
ing two did not show disease signs nor the virus was
recovered from any of the tissues tested. Two of the
three chickens inoculated with rgVac1ins-P2 (H5N1)
showed disease signs, one of them died two days post
inoculation, and the virus was recovered from almost all
samples. P3 viruses efficiently replicated in each of the
tested tissues in chickens as compared with P2 viruses.
Throughout the study, the viruses were recovered from
the brains of all of the chickens showing clinical signs.
Discussion
Here, we demonstrated that the H9N2 influenza virus
acquired intravenous pathogenicity after a pair of di-
basic amino acid residues was introduced into the clea-
vage site of the HA and serially passaged in chicks.
Since rgY55sub-P10 (H9N2) killed 75% of chickens
inoculated via intravenous route, the pathogenicity was
comparable to that of HPAIVs (Table 1). On the other
hand, chickens intranasally inoculated with rgY55sub-
P10 (H9N2) did not show any clinical signs of disease
(Table 4). These results are consistent with those of pre-
vious study showing that some H10 influenza viruses
did not show intranasal pathogenicity for chicken while
their intravenous pathogenicity index was over 1.2 and
classified as HPAIV according to the definition by Eur-
opean Union [29]. Amino acid changes during consecu-
tive passages in the air sacs of chicks (Table 2) are
considered to be responsible for the acquisition of
Table 3 Amino acid changes during consecutive passages of rgVac1 mutants
Passage number rgVac1sub (H5N1) rgVac1ins (H5N1)
PA HA NP M1 M2 HA NA M1
65
a 672 308 338 213 374 89 101 45 157 298 465 171 130
P0 S L H - R M D R R S M D N L
P1 .
b .Q R
c .. . . H P.E. .
P 2 T . Q R.. . K H P.. . .
P3 . F Q R Q V N K H P I . N/H
d I
a Methionine encoded by the AUG start codon is defined as position 1.
b Periods indicate same amino acids as the parental virus.
c Arginine was inserted at the HA cleavage site.
d Amino acid quasispecies were observed.

























0/1 2/3 2/3 (4, 11)
rgVac1sub-P3
(H5N1)






1/1 2/3 2/3 (8, 11)
rgVac1ins-P3
(H5N1)
0/1 2/3 2/3 (4, 6)
a Examined for the survived chickens by HI test and ELISA.
b The number of positive animals/total.
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tions of viral proteins should be clarified further. Here
we focused on two substitutions at positions 29 and 234
of the H9 HA molecule. It has been reported that resi-
due 226, based on the H3 HA numbering (234 in the
present study), relates to receptor specificity and cell
tropism [30]. Strain Y55 (H9N2) originally had a leucine
at this position, and the change to glutamine after serial
passages in the air sacs of chicks indicates that the pas-
saged rgY55sub (H9N2) was further adapted to chicken.
One of the asparagine-linked glycosylation sites on the
HA of rgY55 (H9N2) lost a carbohydrate attachment
with the substitution of Asn29His. The site locates steri-
cally in the vicinity of the HA cleavage site, suggesting
that the deletion of the carbohydrate chain affected the
susceptibility of the HA to the host protease [31]. This
notion is also supported by the present finding that the
rgY55sub viruses (H9N2) after six passages in the air
sacs of chicks replicated in MDCK cells in the absence
of trypsin (Table 1). Ohuchi et al. (1991) reported that
the insertion of additional basic amino acids into the H3
HA cleavage site resulted in intracellular proteolytic
cleavage. Other groups reported that H3 and H6 HAs
tolerated amino acid mutations into their cleavage sites
and the viruses with the mutated HAs replicated in
MDCK and/or QT6 cells in the absence of trypsin
[32,33]. The results in the present study are in agree-
ment with these, namely, cleavage-based activation by
an ubiquitous protease is not restricted to the H5 and
H7 HAs.
rgVac1sub (H5N1) and rgVac1ins (H5N1) acquired
marked intravenous and intranasal pathogenicity after
a few passages in chicks (Table 1). It was reported
that an avirulent H5 virus isolated from a swan
became highly pathogenic in chickens after 24 conse-
cutive passages in the air sacs, followed by five pas-
sages in the brains of chickens [3]. The differences in
time required for the viruses to become highly patho-
genic between these studies depended on the amino
acid motif at the HA cleavage site prior to passaging.
rgVac1sub (H5N1) acquired an arginine at the HA
cleavage site after only one passage in chickens (Figure
1B and Table 3), suggesting that an additional inser-
tion of basic amino acid residues efficiently occurred
in the serial basic amino acid residues at the cleavage
site. One third of the chickens inoculated intranasally
with rgVac1sub-P2 (H5N1) or rgVac1ins-P2 (H5N1)
survived 14 days (Table 4). In addition, one of the
birds was not susceptible to infection with rgVac1sub-
P2 (H5N1), indicating that viral replication may
Table 5 Virus recovery from the chickens intranasally inoculated with each virus




Virus recovery (log EID50/g)
Brain Trachea Lung Liver Kidney Colon Blood
c
rgY55 (H9N2) 3 3 (sacrificed) -, -, -
b -, -, ≦ 1.7 -, -, - -, -, - -, -, - -, -, - -, -, -
rgY55sub (H9N2) 3 3 (sacrificed) -, -, - 5.5, 5.7,
6.5
-, 6.7, 2.7 -, 2.7, - -, -, 2.5 -, -, - -, -, -
rgY55sub-P10
(H9N2)
3 3 (sacrificed) -, -, - -, -, 3.3 -, 3.7, 6.0 -, -, 2.5 -, 4.3, 4.5 -, 3.3, 4.5 -, -, -
rgVac1 (H5N1) 3 3 (sacrificed) -, -, - -, -, - -, -, - -, -, - -, -, - -, -, - -, -, -
rgVac1sub (H5N1) 3 3 (sacrificed) -, -, 2.7 -, -, - -, -, 2.5 -, -, - -, -, - -, -, ≦ 2.0 -, -, -
rgVac1sub-P2
(H5N1)
2 3 (sacrificed) -, - -, - -, - -, - -, - -, - -, -
1




a 3 (dead) 5.7, 6.7 5.3, 6.5 4.7, 8.2 3.5, 6.0 7.3, 9.0 5.5, 6.5 NA
d
1
a 3 (sacrificed) 6.3 6.5 6.7 6.5 6.5 6.5 5.8
rgVac1ins (H5N1) 3 3 (sacrificed) -, ≦ 2.6, - -, 3.5, - -,3.3, 3.7 -, -, 3.5 -, 2.7, 3.0 -, 3.0, 2.5 -, ≦ 1.6,
2.8
rgVac1ins-P2 (H5N1) 1
a 2 (dead) 3.5 3.4 4.7 3.7 4.8 4.7 NA
1
a 3 (sacrificed) 3.8 3.7 3.0 ≦ 2.0 4.7 ≦ 2.0 -
1 3 (sacrificed) -------
rgVac1ins-P3 (H5N1) 3














a Each chicken showed depression.
b 1.5 ≧ (0.5 ≧ for blood samples).
c log EID50/ml.
d Not applicable.
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inoculum.
The intranasal pathogenicity of the mutants of H9N2
virus was different from those of H5N1 mutants while
these viruses replicated in MDCK cells in the absence of
trypsin and killed chickens when inoculated via intrave-
nous route (Tables 1 and 4). The viruses were recovered
from the brain and the blood of some chickens infected
with rgVac1 mutants (H5N1), and morbidity was closely
associated with viral titers in the brain (Table 5). No
viruses were recovered from the brain and the blood of
chickens infected with rgY55 mutants (H9N2), indicating
the reason why rgY55sub-P10 (H9N2) did not show
intranasal pathogenicity. All the viruses passaged in the
air sacs of chicks killed chicken embryos by 48 hours
post allantoic inoculation (data not shown). rgVac1sub-
P3 (H5N1) and rgVac1ins-P3 (H5N1) were more patho-
genic to chicken embryos than rgY55sub-P10 (H9N2);
the allantoic fluids obtainedf r o mt h ee m b r y o n a t e de g g s
inoculated with the H5N1 viruses passaged in the air sacs
were turbid. It was reported that infection of a highly
pathogenic virus was strictly confined to endothelial cells
in chicken embryos or chickens [34,35]. Therefore, it is
suggested that the difference of endotheliotropism
between the H9N2 and H5N1 viruses passaged in the air
sacs affected their intranasal pathogenicity. rgY55sub-P10
(H9N2) was not recovered from the brain and the blood
of chickens although it caused systemic infection
(Table 5), indicating that high levels of viremia followed by
replication in the vascular endothelial cells was prerequisite
for the virus to cross the blood-brain barrier and conse-
quently replicated in the brain. This hypothesis is sup-
ported by the result that rgY55sub-P10 (H9N2) showed
intravenous pathogenicity in chickens; direct injection of
the virus to the blood vessels readily caused viremia, lead-
ing to invasion of the virus to the brain. (Table 1).
H9N2 viruses which have the PARSKR or PARSRR
motifs at their HA cleavage site have been isolated from
turkeys, ostriches, and chickens in Israel and quails in
China [14] although PARSSR motif has been found in
most H9N2 isolates, indicating that such substitutions
with basic amino acid residues occur in nature. If serine
a tt h ec - t e r m i n u so ft h eH A 1o ft h eH 9v i r u sw a ss u b -
stituted with lysine, the amino acid motif would be con-
sistent with that of rgY55sub (H9N2) which acquired
intravenous pathogenicity on consecutive passages in
the air sacs of chicks. LPAI caused by H9N2 strains in
poultry is now causing serious economic losses [11-19],
and its eradication is still difficult because of its low
pathogenicity, frequently causing inapparent infections.
The present study demonstrated that H9N2 viruses cir-
culating in chicken flocks can acquire intravenous
pathogenicity. It is predicted that co-infections of rgY55-
sub-P10 (H9N2) with bacteria exacerbate not only
intravenous pathogenicity but intranasal pathogenicity in
c h i c k e n sa ss h o w ni nap r e v i o us study [21]. Therefore,
continuous monitoring in poultry is important to pre-
vent the emergence of pathogenic H9 viruses.
Materials and methods
Viruses
A/chicken/Yokohama/aq-55/2001 (Y55) (H9N2) isolated
from chicken meat imported from China upon quaran-
tine was kindly provided by Dr. M. Eto, Animal Quaran-
tine Service (Yokohama, Kanagawa, Japan) [36]. A/duck/
Hokkaido/Vac-1/2004 (Vac1) (H5N1) was generated by
the standard genetic reassortment procedure from non-
pathogenic viruses, A/duck/Mongolia/54/2001 (H5N2)
and A/duck/Mongolia/47/2001 (H7N1) [37-39]. Viruses
were propagated in ten-day-old embryonated chicken
eggs for 48 hours at 35°C.
The complete nucleotide sequences of Y55 (H9N2)
and Vac1 (H5N1) have been registered in GenBank/
EMBL/DDBJ (Accession numbers: AB256671-AB256678
[36] and AB259709-AB259716 [37], respectively).
Reverse genetics
Viral RNA was extracted from the allantoic fluid of
embryonated chicken eggs infected with the Y55 and
Vac1 strains using a commercial kit (TRIzol LS Reagent,
Sigma-Aldrich, St. Louis, MO, U.S.A) and reverse-
transcribed with the Uni12 primer [40] and M-MLV
Reverse Transcriptase (Invitrogen, Carlsbad, CA, U.S.A).
PCR-based amplification of the full genomes of the
eight gene segments was performed with universal pri-
mer sets [41]. The PCR products were cloned into the
vector pCR2.1-TOPO (Invitrogen) or pGEM-T Easy
Vector (Promega, Mannheim, Germany). After confir-
matory sequencing, T-vector clones were digested with
BsmBI a n di n s e r t e di n t ot h ev e c t o rp H W 2 0 0 0[ 4 2 ] .
MDCK cells and 293T cells were maintained in Mini-
mum Essential Medium (MEM, Nissui Pharmaceutical,
Tokyo, Japan) containing 10% calf serum and D-MEM
(Invitrogen) containing 10% FBS, respectively. Before
transfection, confluent 293T and MDCK cells in 75 cm
2
flasks were trypsinized, and 10% of each cell line was
mixed in 12 ml of Opti-MEM I (Invitrogen); 2 ml of the
suspension was seeded into each well of six-well tissue
culture plates (Nunc Inc., Naperville, IL). The cocul-
tured 293T and MDCK cells were used for the transfec-
t i o n .T r a n s I T - 2 9 3( P a n v e r a ,M a d i s o n ,W I )w a su s e dt o
transfect cells according to the manufacturer’sd i r e c -
tions. Briefly, two microliters of TransIT-293 per micro-
gram of DNA was mixed, incubated at room
temperature for 45 minutes, and added to the cells. The
transfection mixture was replaced with Opti-MEM I
after six hours of incubation at 37°C. Thirty hours later,
Opti-MEM I containing one microgram per microliter
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Page 6 of 9of trypsin was added. At 48 to 72 hours post-transfec-
tion, the culture supernatant was collected and propa-
gated in ten-day-old embryonated chicken eggs.
Site-directed-mutagenesis
To generate H9 and H5 mutant viruses with basic
amino acid residue substitutions (sub) or insertions (ins)
at the HA cleavage site, mutations were introduced into
the HA genes of the Y55 and Vac1 strains using a Quik-
Change II site-directed mutagenesis kit (Stratagene, Hei-
delberg, Germany) according to the manufacturer’s
instructions. The mutant viruses, rgY55sub (H9N2),
rgVac1sub (H5N1), and rgVac1ins (H5N1), were rescued
by reverse genetics as described above, and the entire
genomes of the eight gene segments were sequenced to
confirm the existence of the introduced mutations and
the absence of undesired mutations.
Plaque assay
Ten-fold dilutions of viruses were inoculated onto con-
fluent monolayers of MDCK cells and incubated at 35°C
for one hour. Unbound viruses were removed by wash-
ing the cells with MEM. Cells were then overlaid with
MEM containing 0.7% Bacto-agar (Difco, Sparks, MD)
in the presence or absence of trypsin (5 μg/ml). After
48 hours of incubation at 35°C, cells were stained with
0.005% neutral red.
Consecutive passage in the air sacs of chicks
The caudal thoracic air sacs of three 3-day-old chicks
were inoculated with 200 μl of each of the mutant Y55
and Vac1 viruses. The chicks were sacrificed, and their
lungs and brains were collected at three days post-inocu-
lation. Serial passages in the air sacs of three to six 3-day-
old chicks were performed with 200 μl of a pooled 10%
tissue suspension of infected organs. Brain samples were
used as the inoculum when both samples (lungs and
brains) tested positive for the virus. Isolates were identi-
fied by their parental strain’s name, mutation (substitu-
tion or insertion), and number of passages. For example,
the designation rgY55sub-P10 (H9N2) indicates that the
amino acids at the HA cleavage site of the Y55 virus were
substituted with basic aminoa c i d sa ss h o w ni nF i g u r e
1A, then passaged ten times in the air sacs. Passaged
viruses were propagated in the allantoic cavities of ten-
day-old embryonated chicken eggs for 48 hours at 35°C.
The allantoic fluid was harvested and stored at -80°C.
Experimental infection of chickens with mutant virus
strains
Four-week-old Boris Brown chickens were used to test
the pathogenicity of the passaged viruses. Eight chickens
were intravenously inoculated with 200 μl of each virus
(1:10 diluted allantoic fluid), and examined for clinical
signs at intervals of 24 hours over a period of ten days.
Similarly, three chickens were infected intranasally with
100 μl of allantoic fluid containing each virus at a EID50
of 10
6.5 and observed for 14 days. Specific antibodies
against homologous viruses after 14 days of infection
were detected in serum using the hemagglutination inhi-
bition (HI) test and/or enzyme-linked immunosorbent
assay (ELISA) as described previously [43]. To study viral
replication, each virus was inoculated into three chickens
at an EID50 of 10
6.5. The birds were euthenized three
days post-challenge, and tissue and blood were collected
aseptically. To make a 10% suspension with MEM, the
tissue samples were homogenized using a Muti-Beads
Shocker (Yasui Kikai, Osaka, Japan). These suspensions
were serially diluted ten-fold with PBS and inoculated
into ten-day-old embryonated eggs and incubated at 35°C
for 48 hours. Viral titers were calculated by the method of
Reed and Muench [44] and expressed as EID50 per gram
and milliliter of tissue and blood, respectively.
All experiments were carried out in self-contained iso-
lator units (Tokiwa Kagaku, Tokyo, Japan) at a BSL3
biosafety facility at the Graduate School of Veterinary
Medicine, Hokkaido University, Japan. The experiments
were performed according to the guidelines of the insti-
tutional animal care and use committee of the Graduate
School of Veterinary Medicine.
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